Disclaimer: Florin|Roebig is no longer accepting claims against Zantac for Chronic Lymphocytic Leukemia (CLL). This content is for informational purposes.
In September 2019, the U.S. Food and Drug Administration (FDA) released a statement informing healthcare providers and patients of a potential link between the use of Zantac (ranitidine) and various cancers.
This link was initially discovered by the online pharmacy, Valisure, which found toxic amounts of a cancerous chemical in ranitidine drugs during a round of routine testing.
Chronic lymphocytic leukemia (CLL), the most common type of leukemia in adults, is one of the types of cancers being investigated for a potential link to the long-term use of Zantac.
The cancerous ingredient found in Zantac—N-nitrosodimethylamine (NDMA)—has a known link to cancers of the blood and bone marrow, according to data from the U.S. Environmental Protection Agency (EPA).
If you or a loved one has been diagnosed with CLL after taking Zantac long-term for a health condition, the Zantac lawyers of Florin|Roebig can offer you a free case evaluation to discuss the details of your case and determine your legal options.
About Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a slow-progressing type of cancer that develops through the mutation of certain white blood cells known as lymphocytes.
Cancer is a disease in which cells in the body begin to grow rapidly and out of control. Unlike acute forms of leukemia, which can progress very fast, people with chronic leukemias may live with leukemia for years before noticing any symptoms.
The exact cause of chronic lymphocytic leukemia is still being studied by cancer researchers, although it has a known link to white blood cell mutations. It is most common in older adults.
This form of leukemia begins in the bone marrow, spreading later to the blood. As the cells continue to grow, leukemia may spread to other areas of the body such as the spleen, lymph nodes, and liver.
Symptoms of chronic lymphocytic leukemia may include:
- swollen lymph nodes
- night sweats
- easy bruising
- pain or sense of ‘fullness’ in the stomach (caused by enlarged liver and/or spleen)
According to the American Cancer Society, chronic leukemias can be more difficult to treat than acute forms. The primary forms of treatment for CLL are chemotherapy, vaccine therapy, and certain drugs that are capable of targeting the gene changes seen in people with CLL.
The Link Between Chronic Lymphocytic Leukemia And Zantac
Zantac was recently discovered to contain excessive amounts of a cancerous chemical known as NDMA. Drug testing by Valisure and other pharmaceutical laboratories have shown Zantac products containing NDMA amounts that are up to 31,000 times higher than the FDA-recommended acceptable daily intake.
Zantac is a popular brand name for drugs containing the active ingredient, ranitidine. It is one of the most widely used drugs worldwide for the treatment of chronic heartburn, acid reflux, and ulcers.
Although unlikely to increase one’s risk for cancer after taking a single dose, NDMA researchers say that regularly ingesting excessive amounts of NDMA in Zantac may increase one’s risk for cancer with long-term use.
Various types of cancer, including cancers of the blood and bone marrow, have long been known to be potential consequences of NDMA overexposure. For this reason, researchers are now investigating a potential link between long-term use of Zantac and leukemias such as CLL.
Risk For Developing Leukemia After Taking Zantac
The risk of developing chronic lymphocytic leukemia (CLL) after taking Zantac is still being investigated by medical and pharmaceutical researchers. This type of leukemia primarily affects older adults and is rarely diagnosed in children or adults under the age of 40.
At this time, the primary population believed to be at risk for developing cancer after taking Zantac is individuals who have been taking the drug regularly (at least twice a week) for an extended period of time.
Zantac (ranitidine) is commonly used as a long-term treatment for certain health conditions. Prior to the recent Zantac recalls, Zantac was available for use through prescription and over-the-counter purchases.
Our Featured Case Results
What To Do If You’ve Developed Chronic Lymphocytic Leukemia After Taking Zantac
The American Cancer Society estimates that there will be 21,040 new diagnoses of chronic lymphocytic leukemia in the United States in 2020 and more than 4,000 CLL-related deaths.
Taking drugs like Zantac for a chronic health condition should not put individuals at risk for developing a life-threatening disease. If you’ve been diagnosed with CLL after taking Zantac, consider taking the following steps:
Talk To Your Doctor
If you’re currently taking Zantac for a health condition, talk to your prescribing doctor before making adjustments to your Zantac dosage. Your doctor may be able to provide you with an alternative treatment option based on the nature of your health condition and your medical history.
If you’re concerned about whether your use of Zantac caused your leukemia diagnosis, this may be a question you can bring to your cancer treatment team. Your treatment team may be able to provide greater insight into whether your use of Zantac may have contributed or led to your diagnosis.
Contact A Zantac Lawyer
Thousands of individuals across the U.S. have filed lawsuits against the pharmaceutical companies who manufacture Zantac on the basis of product liability and negligence.
By failing to disclose the dangerous amounts of NDMA in their Zantac products prior to Valisure’s discovery, our lawyers have determined that these pharmaceutical companies have demonstrated negligent behavior punishable by law.
Plaintiffs suing Zantac drugmakers include people who have been diagnosed with the severe health problems linked to NDMA, as well as surviving loved ones of individuals who died of cancer after taking Zantac.
If you’ve been diagnosed with CLL, or lost a loved one to CLL, after taking Zantac regularly for years, you may be eligible to join others in seeking justice for being unknowingly exposed to a potentially cancerous drug.
We Are Nationally Awarded Lawyers
Top-Rated Zantac Lawyers
At Florin|Roebig, our lawyers have been diligently following the latest updates on Zantac cancer lawsuits and ongoing research into the risks and dangers of widely used Zantac products.
Our Zantac lawyers can determine your eligibility for joining a class action or filing an individual lawsuit for multidistrict litigation—the primary way in which victims are taking legal action against negligent Zantac drugmakers.
Through a free initial case evaluation, our lawyers can assess the details of your case and provide you with an overview of your legal options.
If eligible to file a Zantac lawsuit, recoverable damages may include:
- cancer treatment costs
- projected medical expenses
- pain and suffering
- money spent on Zantac
- lost income
- loss of earning capacity
- wrongful death
Don’t wait to learn how our lawyers may be able to help you or a loved one seek justice for your pain and suffering. Contact us today to schedule a free case evaluation with one of our top-rated Zantac drug lawyers.